Cargando…
A serum metabolic biomarker panel for early rheumatoid arthritis
OBJECTIVE: There is an urgent need for novel biomarkers to improve the early diagnosis of rheumatoid arthritis (ERA). Current serum biomarkers used in the management of ERA, including rheumatoid factor and anti-cyclic citrullinated peptide (ACPA), show limited specificity and sensitivity. Here, we u...
Autores principales: | Rodríguez-Muguruza, Samantha, Altuna-Coy, Antonio, Arreaza-Gil, Verónica, Mendieta-Homs, Marina, Castro-Oreiro, Sonia, Poveda-Elices, Maria José, del Castillo-Piñol, Nuria, Fontova-Garrofé, Ramon, Chacón, Matilde R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502709/ https://www.ncbi.nlm.nih.gov/pubmed/37720214 http://dx.doi.org/10.3389/fimmu.2023.1253913 |
Ejemplares similares
-
A Serum Biomarker Panel of exomiR-451a, exomiR-25-3p and Soluble TWEAK for Early Diagnosis of Rheumatoid Arthritis
por: Rodríguez-Muguruza, Samantha, et al.
Publicado: (2021) -
In silico analysis of prognostic and diagnostic significance of target genes from prostate cancer cell lines derived exomicroRNAs
por: Altuna-Coy, Antonio, et al.
Publicado: (2023) -
Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness
por: Ruiz-Plazas, Xavier, et al.
Publicado: (2019) -
Serum Levels of the Cytokine TWEAK Are Associated with Metabolic Status in Patients with Prostate Cancer and Modulate Cancer Cell Lipid Metabolism In Vitro
por: Altuna-Coy, Antonio, et al.
Publicado: (2021) -
Liquid Biopsy-Based Exo-oncomiRNAs Can Predict Prostate Cancer Aggressiveness
por: Ruiz-Plazas, Xavier, et al.
Publicado: (2021)